13D/13G Filings - Prelude Therapeutics Inc (PRLD)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-01-13
5:34 pm
Purchase
2021-01-1113DPrelude Therapeutics Incorporated
PRLD
ORBIMED ADVISORS LLC14,847,077
31.900%
41,700increase
(+0.28%)
Filing
History
2020-10-05
5:17 pm
Purchase
2020-09-2513DPrelude Therapeutics Incorporated
PRLD
ORBIMED ADVISORS LLC14,805,377
33.900%
14,805,377increase
(New Position)
Filing
History
2020-09-30
5:25 pm
Purchase
2020-09-2413DPrelude Therapeutics Incorporated
PRLD
Baker Bros. Advisors LP10,121,228
31.100%
10,121,228increase
(New Position)
Filing
History
Goto Prev, 0, 1